Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 101.870 | 101.870 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.303 | 18.327 |
Price to Book | 2.417 | 3.749 |
Price to Sales | 3.271 | 5.410 |
Price to Cash Flow | 8.710 | 13.491 |
Dividend Yield | 0.517 | 0.511 |
5 Years Earnings Growth | 8.843 | 21.089 |
Number of long holdings: 35
Number of short holdings: 16
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Exelixis | US30161Q1040 | 9.58 | 33.15 | +0.67% | |
Gilead | US3755581036 | 8.61 | 97.20 | +0.26% | |
Biogen | US09062X1037 | 7.84 | 143.93 | -1.57% | |
Ionis Pharma | US4622221004 | 7.24 | 31.90 | -4.26% | |
Incyte | US45337C1027 | 4.83 | 74.16 | +0.53% | |
Amgen | US0311621009 | 4.82 | 285.42 | +0.49% | |
Alkermes Plc | IE00B56GVS15 | 4.73 | 31.53 | -1.19% | |
Crispr Therapeutics | CH0334081137 | 4.67 | 41.59 | -1.07% | |
Alnylam | US02043Q1076 | 4.52 | 271.31 | -2.11% | |
Jazz Pharma | IE00B4Q5ZN47 | 4.49 | 124.37 | -0.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Selectra J Lamarck Biotech Class B | 71.4M | -18.55 | -10.74 | 2.48 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review